14-50153111-T-C
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2
The NM_006939.4(SOS2):c.2120A>G(p.Glu707Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000197 in 1,603,938 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_006939.4 missense
Scores
Clinical Significance
Conservation
Publications
- Noonan syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Noonan syndrome 9Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -14 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SOS2 | NM_006939.4 | c.2120A>G | p.Glu707Gly | missense_variant | Exon 13 of 23 | ENST00000216373.10 | NP_008870.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152158Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000168 AC: 42AN: 250218 AF XY: 0.000192 show subpopulations
GnomAD4 exome AF: 0.000207 AC: 300AN: 1451662Hom.: 1 Cov.: 26 AF XY: 0.000217 AC XY: 157AN XY: 722870 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000105 AC: 16AN: 152276Hom.: 0 Cov.: 32 AF XY: 0.0000671 AC XY: 5AN XY: 74462 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Noonan syndrome 9 Benign:2
- -
- -
not specified Benign:1
Variant summary: SOS2 c.2120A>G (p.Glu707Gly) results in a non-conservative amino acid change located in the RAS-like guanine nucleotide exchange factor, N-terminal domain (IPR000651), also known as the RAS exchanger motif (REM), of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00017 in 250218 control chromosomes (gnomAD). The observed variant frequency is approximately 67-fold of the estimated maximal expected allele frequency for a pathogenic variant in SOS2 causing Noonan Syndrome phenotype (2.5e-06), strongly suggesting that the variant is benign. c.2120A>G has been reported in the literature in individuals with a clinically diagnosed RASopathy without strong evidence for causation and was considered to be a polymorphism (Cordeddu_2015). Thus this report does not provide unequivocal conclusions about association of the variant with Noonan Syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted a clinical-significance assessment for this variant to ClinVar after 2014 and classified the variant as likely benign. Based on the evidence outlined above, the variant was classified as likely benign. -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at